| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | Marimed Inc: Marimed to release Q3 2026 results Nov. 11 | 1 | Stockwatch | ||
| 24.09. | MariMed Inc.: MariMed's Betty's Eddies Spreads Importance of Cancer Screening Education and Awareness this October through Partnership with Keep A Breast Foundation | 1 | GlobeNewswire (USA) | ||
| 23.09. | MARIMED INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 23.09. | Marimed Inc: Marimed sets vote on proposed reverse stock split | 1 | Stockwatch | ||
| 23.09. | MariMed Inc.: MariMed Files Definitive Proxy Statement for Special Meeting of Stockholders to Approve Proposed Reverse Stock Split | 317 | GlobeNewswire (Europe) | NORWOOD, Mass., Sept. 23, 2026 (GLOBE NEWSWIRE) -- MariMed Inc. ("MariMed" or the "Company") (CSE: MRMD) (OTCQB: MRMD), a leading multi-state cannabis operator focused on improving lives every day... ► Artikel lesen | |
| 17.09. | Marimed Inc: Marimed to open Thrive Dispensary in Columbus Sept. 18 | 3 | Stockwatch | ||
| MARIMED Aktie jetzt für 0€ handeln | |||||
| 17.09. | MariMed Inc.: MariMed Announces Thrive Wellness Dispensary Opening in Columbus, Ohio | 1 | GlobeNewswire (USA) | ||
| 13.08. | MARIMED INC. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 13.08. | Earnings Call: MariMed meldet Rekordumsatz für Q2 2026, Aktie bricht dennoch ein | - | Investing.com Deutsch | ||
| 12.08. | MariMed GAAP EPS of -$0.01 in-line, revenue of $41.93M beats by $2.13M | 1 | Seeking Alpha | ||
| 12.08. | MARIMED INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 12.08. | MariMed Inc.: MariMed Reports Second Quarter 2026 Earnings | 218 | GlobeNewswire (Europe) | NORWOOD, Mass., Aug. 12, 2026 (GLOBE NEWSWIRE) -- MariMed Inc. ("MariMed" or the "Company") (CSE: MRMD) (OTCQB: MRMD), a leading multi-state cannabis operator focused on improving lives every day... ► Artikel lesen | |
| 06.08. | MariMed Inc.: MariMed Embraces Pumpkin Season By Unveiling New Products That Bring Seasonal Autumn Flavors to Cannabis Consumers | 1 | GlobeNewswire (USA) | ||
| 15.07. | Marimed Inc: Marimed to release Q2 results Aug. 12 | 2 | Stockwatch | ||
| 15.07. | MariMed Inc.: MariMed Announces Second Quarter 2026 Earnings Date | 1 | GlobeNewswire (USA) | ||
| 14.07. | Marimed Inc: Marimed rolls out Betty's Bite-A-Mins | 1 | Stockwatch | ||
| 14.07. | MariMed Inc.: MariMed's Betty's Eddies Expands Core Lineup with New Multi-Vitamin Inspired Betty's Bite-A-Mins | 1 | GlobeNewswire (USA) | ||
| 26.06. | Marimed Inc: Marimed applies to register for state-licensed ops | 2 | Stockwatch | ||
| 25.06. | MariMed Inc.: MariMed Submits DEA Registration Applications For State-Licensed Medical Cannabis Businesses | 136 | GlobeNewswire (Europe) | NORWOOD, Mass., June 25, 2026 (GLOBE NEWSWIRE) -- MariMed Inc. ("MariMed" or the "Company") (CSE: MRMD) (OTCQB: MRMD), a leading multi-state cannabis operator, today announced the Company has submitted... ► Artikel lesen | |
| 08.06. | MARIMED INC. - 8-K, Current Report | 1 | SEC Filings |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| AURORA CANNABIS | 3,604 | +2,10 % | Curaleaf Holdings, Inc.: Curaleaf Challenges Aurora's Unilateral Rejection of Its Enhanced Proposal | STAMFORD, Conn., Oct. 19, 2026 /CNW/ -- Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer... ► Artikel lesen | |
| ABBVIE | 255,70 | +0,91 % | Dividendenbekanntmachungen (15.10.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABBOTT LABORATORIES US0028241000 0,63 USD 0,5648 EUR ABBOTT LABORATORIES CDR CA0028221046 0,1096 CAD 0,069 EUR ABBVIE INC US00287Y1091 1... ► Artikel lesen | |
| CANOPY GROWTH | 0,620 | +2,79 % | Trump's Marijuana Order Is Stuck at the DEA. Here's What That Means for Canopy Growth. | ||
| TILRAY BRANDS | 2,580 | -0,96 % | Tilray Brands, Inc.: West Ham United F.C. and BrewDog Unveil Boleyn Brew: A Fan-Created Matchday Beer Made by Hammers, for Hammers | ELLON, Scotland and LONDON, Oct. 21, 2026 (GLOBE NEWSWIRE) -- BrewDog, a leader in U.K. craft beer and one of the world's most recognised beer brands, owned by Tilray Brands, Inc. (NASDAQ: TLRY... ► Artikel lesen | |
| INNOCAN PHARMA | 1,170 | 0,00 % | Innocan Pharma öffnet neuen Verkaufskanal - was folgt? | ||
| TAAT GLOBAL ALTERNATIVES | 0,136 | -100,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.10.2026 -2- | The following instruments on Boerse Frankfurt do have their last trading day on 02.10.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.10.2026ISIN NameCA83013Q8719 CORE... ► Artikel lesen | |
| DERMAPHARM | 38,450 | -0,90 % | JEFFERIES stuft Dermapharm auf 'Hold' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Dermapharm nach einem Treffen mit dem Finanzchef Christof Dreibholz mit einem Kursziel von 44 Euro auf "Hold" belassen.... ► Artikel lesen | |
| CRONOS GROUP | 3,072 | +1,92 % | Cronos Group Inc: Cronos Group completes CanAdelaar acquisition | ||
| SYNBIOTIC | 0,170 | +5,98 % | EQS-Adhoc: SYNBIOTIC SE: Antrag auf Eröffnung eines Insolvenzverfahrens | EQS-Ad-hoc: SYNBIOTIC SE / Schlagwort(e): Insolvenz
SYNBIOTIC SE: Antrag auf Eröffnung eines Insolvenzverfahrens
16.10.2026 / 16:13 CET/CEST
Veröffentlichung einer Insiderinformation... ► Artikel lesen | |
| DIGICANN VENTURES | 0,006 | 0,00 % | XFRA VY3: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| ORGANIGRAM GLOBAL | 0,814 | 0,00 % | Aurora Cannabis: Organigram funkt Curaleaf dazwischen | ||
| GREEN THUMB INDUSTRIES | 5,720 | -1,89 % | President Trump's Push to Reschedule Marijuana Hit a Snag. Is Green Thumb Still a Buy? | ||
| SNDL | 1,112 | -2,80 % | SNDL Inc.: SNDL Announces 2026 Annual and Special Shareholders Meeting Results, Select Preliminary Third Quarter Results and Capital Return Initiatives | ||
| CRESCO LABS | 0,575 | -0,35 % | Cresco Labs Inc: Cresco Labs to release Q3 2026 results Nov. 6 | ||
| NOVERIS HEALTH SCIENCES | 0,032 | 0,00 % | Noveris Health Sciences Inc.: Noveris Health Sciences Announces Results of 2026 Annual General and Special Meeting | Vancouver, British Columbia--(Newsfile Corp. - September 9, 2026) - Noveris Health Sciences Inc. (CSE: NVRS) (FSE: 0NF1) (OTC Pink: MYCOF) (the "Company" or "Noveris") announces the results of its annual... ► Artikel lesen |